Acasti Pharma is developing a product portfolio of proprietary novel long-chain omega-3 phospholipids to focus on treatments for chronic cardiovascular and cardiometabolic conditions within the over-the-counter, medical food, and prescription drug markets. Acasti Pharma’s proprietary novel phospholipids carry and functionalize the polyunsaturated omega-3 fatty acids EPA and DHA, which demonstrate substantial health benefits and which are stabilized by potent antioxidants. For more information visit the company’s Web site at www.acastipharma.com
ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com
Let us hear your thoughts below: